That vaccine passes a trial
- 1 April 1993
- journal article
- Published by Springer Nature in Nature
- Vol. 362 (6419) , 410
- https://doi.org/10.1038/362410a0
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Vaccination with SPf66, a chemically synthesised vaccine, against Plasmodium falciparum malaria in ColombiaThe Lancet, 1993
- Study of the safety and immunogenicity of the synthetic malaria SPf66 vaccine in children aged 1–14 yearsVaccine, 1992
- Malaria vaccines—progress and problemsTrends in Biotechnology, 1991
- The malaria vaccine: anti-parasite or anti-disease?Immunology Today, 1990
- A vaccine candidate from the sexual stage of human malaria that contains EGF-like domainsNature, 1988
- A synthetic vaccine protects humans against challenge with asexual blood stages of Plasmodium falciparum malariaNature, 1988
- Induction of protective immunity against experimental infection with malaria using synthetic peptidesNature, 1987